Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms

[1]  N. Papadopoulos,et al.  IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. , 2014, American journal of respiratory and critical care medicine.

[2]  Andrew McKenzie,et al.  Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation , 2014, Science Translational Medicine.

[3]  W. Thomas,et al.  Comparison of Rhinovirus Antibody Titers in Children With Asthma Exacerbations and Species-Specific Rhinovirus Infection , 2015, Pediatrics.

[4]  S. Johnston,et al.  Airway Inflammation and Illness Severity in Response to Experimental Rhinovirus Infection in Asthma , 2014, Chest.

[5]  W. Thomas,et al.  Species-Specific and Cross-Reactive IgG1 Antibody Binding to Viral Capsid Protein 1 (VP1) Antigens of Human Rhinovirus Species A, B and C , 2013, PloS one.

[6]  Thomas Keil,et al.  Pooling Birth Cohorts in Allergy and Asthma: European Union-Funded Initiatives – A MeDALL, CHICOS, ENRIECO, and GA2LEN Joint Paper , 2012, International Archives of Allergy and Immunology.

[7]  J. Gern,et al.  Clinical and molecular features of human rhinovirus C. , 2012, Microbes and infection.

[8]  Michael D. Davis,et al.  High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus , 2012, Journal of Allergy and Clinical Immunology.

[9]  N. Papadopoulos,et al.  Misdirected antibody responses against an N‐terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Gern,et al.  Updates in the Relationship Between Human Rhinovirus and Asthma , 2011, Allergy, asthma & immunology research.

[11]  Todd W. Sands,et al.  Comparison of Asthma Control Criteria: Importance of Spirometry , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  R. Valenta,et al.  Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation , 2010, European Respiratory Journal.

[13]  A. Nitsche,et al.  Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003 , 2010, Journal of Clinical Virology.

[14]  Wai-ming Lee,et al.  Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. , 2008, American journal of respiratory and critical care medicine.

[15]  S. Johnston,et al.  Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production , 2008, Proceedings of the National Academy of Sciences.

[16]  W. Busse,et al.  The presence of rhinovirus in lower airways of patients with bronchial asthma. , 2008, American journal of respiratory and critical care medicine.

[17]  H. Grönlund,et al.  Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants. , 2007, The Journal of allergy and clinical immunology.

[18]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[19]  S. Johnston,et al.  Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.

[20]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[21]  T. Seemungal,et al.  Longitudinal changes in the nature, severity and frequency of COPD exacerbations , 2003, European Respiratory Journal.

[22]  Stephen T Holgate,et al.  Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.

[23]  S. Johnston,et al.  Peak expiratory flow changes during experimental rhinovirus infection. , 2000, The European respiratory journal.

[24]  E. D. de KLERK,et al.  Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[25]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[26]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[27]  W. Busse,et al.  A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. , 1994, The Journal of clinical investigation.

[28]  E. Kuechler,et al.  Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[30]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[31]  Elliot,et al.  Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. , 1989, The Journal of clinical investigation.